Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release.
J Transl Med
; 22(1): 604, 2024 Jul 01.
Article
in En
| MEDLINE
| ID: mdl-38951906
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phosphoproteins
/
RNA-Binding Proteins
/
Paclitaxel
/
Delayed-Action Preparations
/
Aptamers, Nucleotide
/
Triple Negative Breast Neoplasms
/
Drug Liberation
/
Fluorouracil
/
Nucleolin
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Transl Med
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: